Stocks in Play - 25th February 2026

Today in Focus: YOU

Sources & Services I Use in my Trading:

• Finviz - Scanning, Short Interest, Float, Fundamentals

• Benzinga Pro - News + Squawk

• Tradingview - Charting & Scanning

• BiopharmaIQ - FDA Calendars & Upcoming Biotech Catalysts

• Koyfin - Fundamental Data

• Tradersync - Trade Journal

Situational Awareness

Market Condition: Below all major Moving Averages. Still in tight range. Nice action yesterday but means nothing without some follow through.

Commentary: VIX sell off was welcome. Monitoring that. Lot’s of names gapping up this morning. There are several with good charts that are a pass for me based on earnings but will monitor for RVOL. I’ve posted them in Delayed Reactions area. Cautious on a fade of the gap up.

NVDA earnings after hours. We potentially will see more chop today as nobody probably wants to do anything prior to that.

Upcoming Earnings:
After Hours: NVDA, ZM, URBN, TKO, ADTN, SARO
Before Open: VST, NVAX, HTZ, CRON, Q

Trade Updates:

Current Positions: FSLY, GLW, STM, INNV, VRT, CGNX, NKTR, PVLA, RXT, ROIV

In Play

YOU:  Strong Earnings, Inflection Point.

Key Metrics: Industry Group: Software - Application, Market Cap: 5.39B, Float: 89.17M, Short Interest: 15.38%, Days to Cover: 9.60, Sales Y/Y TTM: 17.83%, EPS Y/Y TTM: 118.70%, Earnings: Feb 25 BMO, Exchange: NASDAQ

Catalyst: Revenue beat, EBITDA strong beat on consensus with 870 bps margin expansion, bookings reaccelerated to strongest growth since Q4 2023, Q1 2026 guidance above Street, dividend raised 20% + special dividend declared. Full-year FCF guidance of ≥$440M (+28.2% YoY) signals sustained capital generation. EBITDA margin inflecting, FCF accelerating.

Good chart. Break above $40 Big base. Needs volume to come in early. Currently low Pre Market. Nice Short Interest. I had this as a pick on Dec 9th for Medicare Integration but it failed.

"We exited the year with accelerating top line growth, delivered record full year profitability and free cash flow... we are at an inflection point for both CLEAR and our industry." "With a robust balance sheet, expanding partnerships and a compelling innovation roadmap, we are entering 2026 from a position of strength." CEO

Delayed Reaction/Continuation Watchlist:

Monitoring:

• CAVA - Good Chart, Red Flags in Earnings

• CRCL - Great earnings bad chart. Genuinely monitoring stable coin theme going forward. Might finally start to develop some legs.

Delayed Reaction Watchlist (TradingView Link)

Like what you're reading? Support this work via ☕ Ko-Fi.

_{Note: This is my methodology for identifying stocks in play. There are many valid approaches to trading catalysts—find the setups, timeframes, and risk parameters that align with your strategy.}